Back to results
US 7,582,759 B2Granted
Diastereomeric purification of rosuvastatin
AssigneeTeva Pharmaceutical Industries Ltd.
InventorsValerie Niddam-Hildesheim, Natalia Shenkar, Kobi Chen, Anna Balanov
Life of this patent
Estimating the term…
Abstract
The invention relates to diastereomerically pure rosuvastatin and processes for preparing diastereomerically pure rosuvastatin and its intermediates.
Claims20
A one pot process for preparing rosuvastatin or a pharmaceutically acceptable salt thereof comprising:
- a) combining MeO-9-BBN with an organic solvent and a source of hydride ions;
- b) adding to said combination a solution of a rosuvastatin intermediate keto-ester in an organic solvent, wherein the rosuvastatin intermediate keto-ester has the following formula:
- wherein X is hydrogen or forms a double bond to provide a ketone, with the proviso that at least one X forms a double bond, and R1 is a carboxy protecting group, to obtain a reaction mixture;
- c) maintaining the reaction mixture to reduce the intermediate;
- and
- d) hydrolyzing the reduced intermediate to rosuvastatin or a pharmaceutically acceptable salt thereof.
3 more elements
Dependencies are inferred from the claim text.